US PTAB Patent Cases
5,620 decisions indexed
Page 3 of 188 · 5,620 total
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
Uber and its freight subsidiary have filed an IPR petition seeking to invalidate Carma Technology’s 7,840,427 patent covering shared‑transport routing. The petition relies on the Olmi UK patent application as both anticipatory and obvious prior art for the asserted claims.
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
Uber has filed an IPR petition seeking to invalidate Carma Technology’s ridesharing patent (US 11,017,668) on the basis that its claims are obvious over several prior‑art references. The petition lists two grounds covering all 20 claims and requests institution of the review.
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
Uber has filed an IPR petition challenging Carma’s ’138 ride‑sharing patent, asserting that the claims are obvious over existing transport‑sharing systems disclosed in Olmi, Gaspard, Thomas and Wolfe.
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
Uber has filed an IPR petition seeking to invalidate twelve claims of Carma’s ridesharing patent, arguing they are obvious over prior‑art references Olmi, Paul, and Jarvinen. The petition includes detailed claim constructions and a single obviousness ground under 35 U.S.C. §103.
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
Uber has filed an IPR petition challenging Carma’s ’456 patent covering shared transport systems. The petition asserts obviousness over O’Sullivan and Olmi references and argues lack of written‑description support. Uber seeks institution of the IPR.
Microsoft Corporation v.ToutVirtual, Inc.
Microsoft petitions the PTAB to invalidate ToutVirtual’s virtual‑systems‑management patent, asserting anticipation and obviousness over multiple prior‑art references and a lack of priority for half the claims.
Microsoft Corporation v.Qomplx LLC
Microsoft has filed an IPR petition seeking to invalidate 13 claims of Qomplx’s 2025 patent on graph‑based cyber‑attack detection, asserting obviousness over two earlier publications. The petition argues that each claim element is fully disclosed in Brezinski and Crabtree, and no evidence of non‑obviousness is offered.
Apple Inc. v.IngenioSpec, LLC
Apple has filed an IPR petition targeting claim 55 of IngenioSpec’s ’355 patent covering wearable audio devices. The petition asserts the claim is obvious over prior‑art hearing‑aid patents and a textbook, and asks the Board to institute review and cancel the claim.
Paragon 28, Inc. v.Treace Medical Concepts, Inc.
Paragon 28 seeks to invalidate Treace’s 12,349,941 bunion‑correction patent, alleging lack of written description, enablement, and obviousness over prior surgical methods and devices. The petition requests cancellation of all 27 claims.
FanDuel, Inc. et al. v.WinView IP Holdings, LLC
FanDuel has petitioned the PTAB to invalidate WinView’s ‘349 patent covering synchronized live‑sports gaming, asserting that a 1998 European filing anticipates all challenged claims.
Toyota Motor Corporation et al. v.BUNKER HILL TECHNOLOGIES, LLC
Toyota has filed an IPR petition seeking to invalidate Bunker Hill’s U.S. Patent 10,549,648 covering hybrid‑electric vehicle propulsion. The challenger alleges anticipation and obviousness over three prior‑art references and requests cancellation of all 20 claims.
Amazon.com Services LLC et al. v.Smart Speaker LLC
Amazon has filed an IPR petition challenging Smart Speaker’s ’721 smart‑home patent, asserting that all asserted claims are obvious over a suite of prior‑art references.
Fifth Third Bank, National Association v.United Services Automobile Association
USAA and Regions Bank have reached a settlement in principle and jointly moved to stay all case deadlines while finalizing the agreement. The motion seeks a 14‑day stay to allow filing of dismissal papers.
Okta, Inc. et al. v.Thales DIS France SAS
Okta has filed an IPR petition seeking cancellation of all ten claims of Thales' ’982 patent covering biometric hash‑based authentication. The petition alleges obviousness over a combination of Starner, Leskovec, Shaashua, and Bowman references.
Fifth Third Bank, National Association v.United Services Automobile Association
Fifth Third Bank has filed a petition to institute an IPR against US Patent 12,211,095 covering mobile check‑deposit technology. The petition alleges that all 30 claims are obvious over a combination of earlier mobile imaging references. It seeks cancellation of the entire patent.
Sarepta Therapeutics, Inc. et al. v.Genzyme Corporation et al.
Sarepta filed an IPR petition seeking to invalidate Genzyme’s ’313 AAV detection patent. The petition asserts that all 27 claims are obvious in view of earlier publications on LC‑MS and RP‑HPLC analysis of viral proteins. No secondary considerations are believed to overcome the obviousness argument.
Cisco Systems, Inc. v.Vusura Technology LLC
Cisco has filed an IPR petition seeking to invalidate claims 1‑25 of Vusura’s ’303 patent, which covers multimedia content presentation during telephone calls. The challenger relies on the 2007 Roundtree publication to argue obviousness under §103.
CRRC Meishan Co. Ltd. et al. v.Howmet Aerospace Inc.
CRRC Meishan has filed an IPR petition challenging all 20 claims of Howmet Aerospace’s blind‑fastener patent, asserting anticipation and obviousness over multiple prior‑art references including Corbett 2018, Corbett 1981, Hurd, Sadri, and the BobTail catalog.
Medtronic, Inc. v.Moskowitz Family LLC
Medtronic has filed a petition for inter partes review of Moskowitz Family’s U.S. Patent 10,064,738 covering spinal intervertebral fusion devices. The challenger alleges that the parent application Moskowitz 440, together with Waugh (and Michelson 019), makes the asserted claims obvious under 35 U.S.C. §103. The petition seeks cancellation of 16 claims.
IPG Photonics Corporation v.Trumpf Laser- Und Systemtechnik GMBH
IPG Photonics has filed an IPR petition seeking cancellation of all 20 claims of TRUMPF’s ’054 laser‑fiber patent, alleging obviousness over a suite of prior‑art fiber‑laser references. The petition outlines four grounds covering the full claim set.
SEG Solar, Inc. et al. v.--
SEG Solar and affiliated entities have filed an IPR petition challenging Jinko's 2023 solar‑cell patent, asserting that 18 claims are obvious over multiple Chinese patents and academic papers. The petition lays out detailed claim‑by‑claim mappings to prior art and seeks cancellation under § 318(b).
X Corp., v.Search & Share Technologies, LLC
X Corp. has filed an IPR petition seeking cancellation of all 14 claims of the ’952 patent, alleging anticipation and obviousness over the Malla, Walther, and Smadja references under §§ 102 and 103.
Google LLC v.Valtrus Innovation Limited et al.
Google petitions the PTAB to invalidate claims 14‑21 and 24‑28 of U.S. Patent 7,057,509, asserting anticipation and obviousness over multiple prior‑art systems for object monitoring and tracking.
Hyundai Motor America, Inc. v.Germ Dome Industries LLC
Hyundai Motor America has filed a post‑grant review petition seeking cancellation of all twenty claims of Germ Dome’s UV sanitizing patent, alleging anticipation by a 2003 Japanese patent and obviousness over that reference alone and in combination with a later U.S. application. The petition relies on extensive claim‑by‑claim comparisons to prior art.
Apple Inc. v.WeCrevention, Inc.
Apple has filed an IPR petition seeking to invalidate all 31 claims of WeCrevention’s high‑speed memory chip patent. The petition argues that each claim is obvious over a combination of prior‑art references covering memory modules, ASIC controllers, and 3‑D stacking techniques.
Merck Sharp & Dohme LLC v.Surrozen Operating, Inc. et al.
Merck has filed a post‑grant review petition challenging U.S. Patent 12,297,278 covering broad tetravalent Wnt‑surrogate antibodies. The petition asserts lack of written description, enablement, indefiniteness, and anticipation by the Garcia publication.
Apple Inc. v.IngenioSpec, LLC
Apple has filed an IPR petition against IngenioSpec’s ’901 patent covering smart eyeglasses, asserting that all 59 claims are obvious over multiple prior‑art references and requesting cancellation of the entire patent.
Bicara Therapeutics, Inc. v.The John Hopkins University et al.
Bicara Therapeutics has filed a PTAB Post‑Grant Review petition seeking cancellation of all nine claims of Johns Hopkins' 2025 antibody‑fusion protein patent, alleging lack of written description, lack of enablement, and improper claim dependency.
Dolby Laboratories, Inc. et al. v.InterDigital Madison Patent Holdings, SAS et al.
Dolby Laboratories has filed an IPR petition challenging U.S. Patent 9,185,268, which covers methods for color correcting display content. The petition asserts that the claims are obvious over a combination of prior‑art references and requests the Board to institute the review.
Biocon Biologics Limited et al. v.--
Biocon has filed a PGR petition seeking to invalidate all 38 claims of Regeneron’s ‘036 anti‑VEGF eye‑treatment patent, alleging obviousness over prior art and lack of written description.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.